Literature DB >> 35923383

Identification and Implications of HIV-1 CRF01_AE Subtype in Hawai'i.

Logan S Dean1, Ivo N SahBandar2, Cecilia M Shikuma1.   

Abstract

Human Immunodeficiency Virus has a high propensity for genetic variation, demonstrated by its complex phylogeny and multiplicity of subtypes. Subtype B is predominant in North America as well as in Hawai'i while CRF01_AE is found in over 50% of cases in the Philippines and Southeast Asia. In a small collaborative study between the Hawai'i Center for AIDS and Philippines General Hospital, molecular phylogenetic subtyping was conducted on HIV+ participants. Two of 15 (13%) participants from the Hawai'i cohort and 12 of 21 (57%) participants from the Philippines cohort were identified as having CRF01_AE subtype of HIV-1, with remaining participants identified as subtype B. While one individual in Hawai'i with CRF01_AE had emigrated from the Philippines, the other participant from Hawai'i with CRF01_AE subtype was a local individual, born and raised in Hawai'i. The authors report that HIV subtype diversity may be increased in Hawai'i and discuss its potential clinical and public health implications. ©Copyright 2022 by University Health Partners of Hawai‘i (UHP Hawai‘i).

Entities:  

Keywords:  CRF01_AE; HIV; Hawai‘i; Philippines

Mesh:

Year:  2022        PMID: 35923383      PMCID: PMC9344534     

Source DB:  PubMed          Journal:  Hawaii J Health Soc Welf        ISSN: 2641-5216


  17 in total

1.  Diversity and characterization of HIV-1 subtypes in the United States, 2008-2016.

Authors:  Richard L Kline; Neeraja Saduvala; Tianchi Zhang; Alexandra M Oster
Journal:  Ann Epidemiol       Date:  2019-03-06       Impact factor: 3.797

Review 2.  The HIV coreceptor switch: a population dynamical perspective.

Authors:  Roland R Regoes; Sebastian Bonhoeffer
Journal:  Trends Microbiol       Date:  2005-06       Impact factor: 17.079

Review 3.  The challenge of HIV-1 subtype diversity.

Authors:  Barbara S Taylor; Magdalena E Sobieszczyk; Francine E McCutchan; Scott M Hammer
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

Review 4.  Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment.

Authors:  Andrew W Woodham; Joseph G Skeate; Adriana M Sanna; Julia R Taylor; Diane M Da Silva; Paula M Cannon; W Martin Kast
Journal:  AIDS Patient Care STDS       Date:  2016-07       Impact factor: 5.078

5.  CRF01_AE and CRF01_AE Cluster 4 Are Associated With Poor Immune Recovery in Chinese Patients Under Combination Antiretroviral Therapy.

Authors:  Zhangwen Ge; Yi Feng; Kang Li; Bowen Lv; Silvere D Zaongo; Jia Sun; Yanling Liang; Dan Liu; Hui Xing; Min Wei; Ping Ma; Yiming Shao
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 9.079

6.  HIV-1 subtype diversity among clinical specimens submitted for routine antiviral drug resistance testing in the United States.

Authors:  Jeffrey J Germer; Puqiang Wu; Jason D Soderberg; Jayawant N Mandrekar; Joseph D Yao
Journal:  Diagn Microbiol Infect Dis       Date:  2015-07-26       Impact factor: 2.803

Review 7.  HIV subtype diversity worldwide.

Authors:  Nicholas Bbosa; Pontiano Kaleebu; Deogratius Ssemwanga
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

8.  HIV-1 CRF01_AE strain is associated with faster HIV/AIDS progression in Jiangsu Province, China.

Authors:  Minjie Chu; Wuhong Zhang; Xuan Zhang; Wenjie Jiang; Xiping Huan; Xiaojun Meng; Bowen Zhu; Yue Yang; Yusha Tao; Tian Tian; Yihua Lu; Liying Jiang; Lei Zhang; Xun Zhuang
Journal:  Sci Rep       Date:  2017-05-08       Impact factor: 4.379

Review 9.  Maraviroc: a review of its use in HIV infection and beyond.

Authors:  Shawna M Woollard; Georgette D Kanmogne
Journal:  Drug Des Devel Ther       Date:  2015-10-01       Impact factor: 4.162

10.  Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.

Authors:  Bridgette J Connell; Lucas E Hermans; Annemarie M J Wensing; Ingrid Schellens; Pauline J Schipper; Petra M van Ham; Dorien T C M de Jong; Sigrid Otto; Tholakele Mathe; Robert Moraba; José A M Borghans; Maria A Papathanasopoulos; Zita Kruize; Francois W D Venter; Neeltje A Kootstra; Hugo Tempelman; Kiki Tesselaar; Monique Nijhuis
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.